Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial

Zikun Peng, Huayi Li, Yunong Gao, Li Sun, Jie Jiang, Bairong Xia, Yi Huang, Yu Xia, Yuxin Zhang, Yiyang Shen,

The Lancet Oncology · 2024 · 30 citations · 22 references

Concepts

References

22